EVTCY
Evotec AG

260
Loading...
Loading...
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
4,827

Frequently Asked Questions

What is Market Cap of Evotec SE - ADR?
What is the 52-week high for Evotec SE - ADR?
What is the 52-week low for Evotec SE - ADR?
What is Evotec SE - ADR stock price today?
What was Evotec SE - ADR stock price yesterday?
What is the PE ratio of Evotec SE - ADR?
What is the Price-to-Book ratio of Evotec SE - ADR?
What is the 50-day moving average of Evotec SE - ADR?
How many employess does Evotec SE - ADR has?

Latest EVTCY News

View
No EVTCY news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.